chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt became stiff, turned blue, vomited, shivering, unconscious with 104 F fever about 7 hrs after shots. Pt. appeared normal without fever until then. Paramedic was called & brought him to ER. Chest x-ray & CBC - normal. Released him. Bluishness, stiffness lasted approximately 10 min. Awake in 30 min.
About 10 days after vaccines, our daughter stopped to smile, to talk, to look at us. She was withdrawn.  She had loose stool. Following week I noted abnormal hand motion when reaching for things, I believe she had subtle ataxia. Her walking was more unsteady too.  She was withdrawn, but at times hyperactive, for example climbing her bed and wall, which she never did before. Week 3-4 she had facial rash. Week 4-5 she arched her back. We were told by Dr that she has rare side effect from vaccines called developmental regression. I myself believe she had aseptic meningitis. I am a physician. What is on paper in her chart is speech, emotional and social delay. Our daughter was perfectly fine in regards of social, emotional and speech (in fact growing up in tri-lingual home) till about 10 days after above vaccinations.  We were told that "time will show" what the outcome will be.  We are now 7 months later, working on speech therapy.
Pfizer-BioNTech COVID-19 Vaccine EUA On 3/31/2021 I developed a headache, fatigue, ringing in ears and tachycardia.  Later that night I developed hives on my forehead that was resolved with oral Benadryl.  On 4/22/2021 I developed burning fatigue in my arms and legs, the headache and ringing in ears have still continued.  I saw my PCP on 4/26/2021 for daily headaches, ringing in ears and fatigue/burning in arms that started after receiving the Pfizer vaccine.  A prednisone dose pack was prescribed.  I am currently on day 4 of steroids and fatigue has improved slightly, still having headaches and ringing in ears.
Swollen, red, tender, hard, and giving off heat at site of injection. Lymph nodes on same arm are swollen as well. Headache, fatigue, dizziness, random spurts of sweating, and not wanting to eat anything. All started day after vaccine. I have taken Benadryl that helped significantly started taking on Friday(3/12/21). Lymph nodes are still swelling and injection area is starting to itch.
PAIN IN RIGHT NECK; PAINFUL ARM, PAIN IN ARM/PAIN IN UNDERARM, EXTREME SORENESS ON RIGHT ARM; HURTS TO MOVE RIGHT HAND; SWOLLEN LYMPH NODES ON RIGHT ARM, RIGHT ARMPIT AND NECK; PAIN ON INJECTION SITE INTO SHOULDER; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergies to narcotics, and other pre-existing medical conditions included sensitivity to most western medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced pain on injection site into shoulder. On 12-APR-2021, the subject experienced swollen lymph nodes on right arm, right armpit and neck. On 12-APR-2021, the subject experienced hurts to move right hand. On 18-APR-2021, the subject experienced pain in right neck. On 18-APR-2021, the subject experienced painful arm, pain in arm/pain in underarm, extreme soreness on right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swollen lymph nodes on right arm, right armpit and neck, painful arm, pain in arm/pain in underarm, extreme soreness on right arm, pain in right neck, and hurts to move right hand, and the outcome of pain on injection site into shoulder was not reported. This report was non-serious.; Sender's Comments: V0:As per standard protocol,  comment is not required for nonserious case.
Initial information received on 21Aug06 from a health care professional. It was reported that a 79 yr old female pt received an initial dose of Adacel, lot C2457AA, admin IM in the left deltoid on 28Jun06 at 2:30PM. 30 mins post vaccination, the pt left the physician's office wheezing and feeling short of breath. She was treated with albuterol and prednisone on 03Jul06. On 08Jul06, the pt developed a non productive cough, wheezing, and chest tightness. A chest x ray showed no significant abnormalities. The pt was treated with Augmentin, Mucinex and prednisone. On 11Jul06, the pt was feeling better after the prednisone and continued taking Augmentin. Her shortness of breath and cough continued and she was started on Flovent. On 24Jul06, the pt's cough was worse and she was started on Bactrim. On 05Aug06, the pt began coughing again and was again treated with prednisone and albuterol, as well as Advair. On 14Aug06, her cough was worse again. The pt has not recovered from the events. The pt has a past medical history of seizure disorder, mild asthma, renal disorder and osteomalacia. She has no known drug allergies. She has no history of adverse event following prior vaccination and had no illnesses at the time of vaccination on 28Jun06.
I got my second dose of Pfizer on 9/30/2021. Within the first 6 minutes, the fingers, hand, and arm on my left side began to feel tingly. Within an hour and a half, the left side of my face, neck, torso, and hip also felt tingly. I developed a headache 3 or 4 hours after the injection, and it progressed to a migraine late that night. The migraine continues to persist to the present. The pain is mainly on the left side of my head, behind my eye, and on the temple. At times, the pain diffuses down to the left jaw. With the second vaccine, I also developed acid reflux, which lasted from 9/30/2021 until about 10/26/2021. I also developed joint stiffness and body aches, which began on 10/1/2021 and lasted for 2 or 3 days.
Pt went unresponsive at home per wife, was transported to hospital by EMS and died after getting to the hospital. This is not a suspected allergic reaction to the COVID Moderna vaccine at this time.
felt sick; sore arm; body aches; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to vaccine (mild reaction to flu vaccine), Allergy to nuts (walnuts), Fruit allergy (kiwis), Allergy (a bad reaction to laundry detergent) and Latex allergy (a bad reaction to latex).    On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced ILLNESS (felt sick), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, ILLNESS (felt sick), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            No concomitant medications were reported. No treatment related information has been reported.
Information has been received from a physician concerning a 20-21 year old female with allergic to cats and no known drug allergies who on 01-OCT-2009 was vaccinated with the third dose of GARDASIL (lot number not reported). There was no concomitant medication. On 04-OCT-2009 3 days after the third dose, the patient developed hives (petechial rash on lower extremities), angioedema, right eye swelling, shortness of breath and abdominal pain and was hospitalized. The patient was hospitalized several times, all testing came back normal. The patient was treated with steroids. The patient's hives (petechial rash on lower extremities) and angioedema and right eye swelling and shortness of breath and abdominal pain persisted. No further information is available.
Myoclonic jerks and involuntary movements with a few hours of receiving Gardasil and DPT vaccines at her PCP office.  Seen in ER on 6/30 and received Ativan, Benadryl, fluids.  Seen in my neurology clinic 7/2 with some residual involuntary movements of the right hand and arm.  Bloodwork on 6/30 (BMP, LFTs, TSH, Calcium) was normal.  I ordered CPK and Brain MRI 7/2 (but not completed as of today).
Multiple vial injection; Vaccine was issued past the 6 hour time frame; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Multiple vial injection) and EXPIRED PRODUCT ADMINISTERED (Vaccine was issued past the 6 hour time frame) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Multiple vial injection) and EXPIRED PRODUCT ADMINISTERED (Vaccine was issued past the 6 hour time frame). On 01-Apr-2021, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Multiple vial injection) and EXPIRED PRODUCT ADMINISTERED (Vaccine was issued past the 6 hour time frame) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  No treatment information was provided.
black stool; sinus infection; feels shaky; red dots over the right side of her face; throat feels swollen, inside of lips are swollen; throat feels swollen, inside of lips are swollen; shortness of breath; weak; cough; headache; Initial information received on 10-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional via call center via Agency (Reference number- 00893533).  This case involves a 79-year-old female patient who experienced weak (asthenia), headache, black stool (faeces discoloured), shortness of breath (dyspnoea), cough, sinus infection (sinusitis), feels shaky (tremor), red dots over the right side of her face (rash erythematous) and throat feels swollen, inside of lips were swollen (lip swelling and pharyngeal swelling) after receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's medical history, medical treatments, concomitant medication and family history were not provided.  She received FLUZONE HD in 2020 and felt very weak and tired and that symptoms went on for 6 weeks before improvement.  On 10-Nov-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number and expiry date not reported) via an unknown route in the right arm for prophylactic vaccination.  On an unknown date, the patient developed a non-serious weak (asthenia), headache, black stool (faeces discoloured), shortness of breath (dyspnoea), cough, sinus infection (sinusitis), feels shaky (tremor), red dots over the right side of her face (rash erythematous) and throat feels swollen, inside of lips were swollen (lip swelling and pharyngeal swelling) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was reported "Caller stated she took left over antibiotics from a dental surgery and they improved her condition. Caller did not want to get flu shot this year, but decided to get it 10Nov2021. Caller said she felt fine for a couple of days, but then symptoms started."  She had been to the doctor and tested for COVID which was negative.  It was not reported if the patient received a corrective treatment for the events.  The outcome was unknown for the events.  There will be no information available on the batch number for this case.
2wk p/vax pt devel fever & rash w/c resembled like measles, when fever was high, had sz;
COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Gastro-intestinal disorder NOS. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Gastro-intestinal disorder NOS.    On 19-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced COVID-19 (COVID). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Nasal stuffiness, at an unspecified dose and frequency and PSEUDOEPHEDRINE for Nasal stuffiness, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2022, SARS-CoV-2 test: Positive. On 19-Dec-2022, SARS-CoV-2 test: Positive.         Patient was fully vaccinated. Patient tested 3 to 4 days ago. Patient took Paxlovid the last one on the 17Dec2022 and the rebound started 5 days after patient completed treatment. Patient test positive on 19Dec2022 again. Patient did not have a fever but had the similar symptoms that stuffy nose, lot of secretions, coughing a little bit, not severely. The 19Dec2022 was the third day that patient got infected.
pt exp t104, joint pain, cloudy urine; mom talked w/MD t99, couldn't walk; adm to hosp; joints swollen; MD feels it is rxn to MMR vax;
Mother reports around 410 patient was going upstairs while feeling feels dizzy. Patient reports lowering herself to the ground and then recalls waking up.  Went to ED 17 year old female presents to ED for syncopal event. Upon initial assessment, Pt. Alert, NAD, non toxic appearing. Interactive, answering questions appropriately. Gait steady. Balane intact. Strength equal bilaterally. Head atraumatic. PERRL. EOM intact. Vision and hearing intact. VSS. RR even and unlabored. LSCTA. Skin PWD. MMM. Abd. Soft, non distneded. Non tender. Orthostatic VS unremarkable. EKG NSR. Discussed possible adverse effect r/t vaccine vs. Syncope r/t change of position quickly. Upon reassessment, pt. Remained in NAD, RR even and unlabored, VSS, tolerating PO. Pat. And mother agreeable to discharge
RED,SWOLLEN, FELLS HOT WHEN TOUCH, LT ARM LUMP.
Felt extreme heat through body; Face and neck were bright red; Felt dizzy; Right side of body felt strange; Having a stroke; Nasty allergic reaction; This spontaneous case, initially received from other non-health professional via Merck (00986633) on 24-Oct-2018, concerns a female patient of an unspecified age.  The patient's historical vaccine included Afluria vaccine on an unspecified date in 2015 and 2016 (reported as past three years) for unknown indications.  On an unspecified date in 2017, the patient was administered Afluria (TIV) (influenza vaccine, dose, route of administration, anatomical location, batch number and expiry date: not reported) for an unknown indication.  On the same day, within 20 minutes after vaccination, the patient experienced extreme heat through her body and her face and neck were bright red. The patient felt dizzy and the right side of her body felt strange. The patient experienced nasty allergic reaction which she described as having a stroke (coded as post procedural stroke). The patient sat on her car until the symptoms had resolved.  At the time of this report, the outcome of the events was recovered.; Reporter's Comments: A female patient of an unspecified age experienced allergic reaction, sensation of heat, redness of face and neck, dizziness, right side of her body felt strange and had post procedural stroke, within 20 minutes after the administration of Afluria (TIV). The compnay assessed the causality as related due to plausible temporal relationship between the events and suspect vaccine.
Suspected TIA; Experienced a numbness in right hand, arm, drooping right side of face; Experienced a numbness in right hand, arm, drooping right side of face; slurred speech; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), first dose in right arm on 05Mar2021 14:30 (Lot: EN6199) and second dose in left arm on 26Mar2021 14:30 (Lot: ER8732); both via an unspecified route of administration (at the age of 58-years-old) as single dose for covid-19 immunisation. The vaccination facility type was a public health department. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to bnt162b2. Medical history included allergy induced asthma and seasonal allergies. The patient's concomitant medications were not reported. The patient experienced a numbness in right hand, arm, drooping right side of face and slurred speech, it lasted for 1-2 minutes. The patient went to the ER. Suspected TIA. These events started on 11Apr2021 at 10:00. The events resulted in emergency room/department or urgent care. The patient received unspecified treatment for the events. On 10Apr2021, nasal swab was negative. On 11Apr2021, Covid test type post vaccination with unknown results, rapid and nasal swab was negative. It was reported that the patient had MRI, CT, EKG with unknown results on unspecified dates. The outcome of the events was recovering.
received only the diluent portion; received only the diluent portion; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 2-month-old patient who received Rota (Rotarix lyophilized formulation) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On an unknown date, the patient received the 1st dose of Rotarix lyophilized formulation and Rotarix Oral Applicator Device. On an unknown date, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 21-Nov-2022 Reporter's comment: The health care professional reported that another health care professional called her and mentioned that the patient received a dose in series of the Rotarix with only the diluent portion and wanted guidance on how to proceed.  The reporter was unsure when the maladministration occurred.  No reactions were reported. The reporter consented to follow-up , email follow-up was preferred. Additional supportive information: The patient received only diluent portion of Rotarix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Pain and Tightness in the chest, Severe pain in hip and back leaving patient unable to walk, Numbness and Tingling in the extremities, dizziness, Bells Palsy, Muscle Pain, debilitating joint pain.
Severe knee pain -- Arthritis flareup? I did not have this before the vaccine. It was debilitating enough I was using a cane and needed a wheel chair at times. Meloxicam has helped alleviate some symptoms, but I am still in pain
Visibly swollen lymph nodes under both arms (armpits), painful to the touch and tenderness radiating into the outer breast tissue and down the arms; spiderweb bruising under the armpits
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age, race, ethnicity and gender received a single dose of TRUMENBA and a dose of GARDASIL  (Merck & Co., Inc.), both via an unspecified route of administration on an unspecified date for immunization.  The patient medical history and concomitant medications were not reported.  At the same time of the vaccinations, on an unspecified date, the patient experienced Guillain Barre. The outcome of the event was unknown.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
Within a few hours of receiving Hep B vaccine 1, patient noted circular red raised dry rash/lesions, approximately 1/2-3/4 inch in diameter, on bilateral hands. Spread up to wrists and forearms over the next 2 days, then began to resolve. Probable Erythema Multiforme.
Patient initially experienced dizziness, sweating and blurriness. The symptoms increased to lips tingling and arms feeling heavy. blood dropped slightly and felt nauseous
11/25/16 - Patient experienced redness and swelling down from injection site towards elbow. No pain. Pt. applied ice pack. Reported 11/25/16 PM - swelling going down . 11/27/16 Patient came by Pharmacy - redness/swelling got worse 11/26/16 PM. Pt went to ED.